Start-Up Secures Funding for Fighting Fidos
A new defence-tech firm called Warhound has launched with $200 million in start-up funding, aiming to genetically engineer and technologically equip elite working dogs for the US military and law enforcement.
The venture brings together Ben Lamm, CEO of “de-extinction” firm Colossal Biosciences, and Palmer Luckey, founder of defence contractor Anduril Industries. Led by former Pentagon chief data officer David Spirk, Warhound’s primary objective is to build a domestic supply chain for working dogs, reducing the US military’s roughly 80 percent reliance on European breeders.
Warhound plans to combine cloning and gene-editing technologies to breed canines – primarily Belgian Malinois, German Shepherds and Labradors – with enhanced resilience. Scientists will initially target hereditary vulnerabilities like hip dysplasia, muscle atrophy and cancer predispositions to reduce training washout rates. Future plans involve optimising agility and scent detection.
Alongside genetic enhancement, the dogs and their handlers will receive gear developed by Anduril. These include eye and ear protection, body armor and integration with Anduril’s EagleEye mixed-reality system for real-time battlefield information.
Despite securing backing from prominent investors like Sequoia Capital and CIA-founded In-Q-Tel, the project has raised scientific and ethical qualms. Bioethicists caution that canine cloning remains inefficient and invasive, while the long-term impacts of genetic edits remain uncertain.
Warhound insists animal welfare is a priority, securing certification from the American Humane Society. The company has already biobanked donor cells, with the first litters expected to arrive in early 2027.
